Certara Creates Preeminent Global Strategic Modeling and Simulation Consultancy
New Entity Combines Certara’s Leading Model-based Drug Development Business with Scientific Powerhouse, Quantitative Solutions PRINCETON, NJ – July 8, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced the merger of its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, Calif. This … Continued